Biodesix, Inc.BDSXNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+118.5%
5Y CAGR+50.2%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+118.5%/yr
Annual compound
5Y CAGR
+50.2%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
7.6x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 25.55% |
| 2024 | -4.30% |
| 2023 | -23.77% |
| 2022 | 2.45% |
| 2021 | 18.22% |
| 2020 | 3.34% |
| 2019 | 27.85% |
| 2018 | 0.00% |